Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Nerve Decompression.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome.

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma.

Dr. Alassas is a 2021 Seattle Met Top Doctor Award winner. Dr. Alassas is a specialized surgical oncologist with extensive experience in complex abdominal and oncologic surgery. He is dedicated to delivering the best quality care and highest level of safety to his patients. His treatment philosophy is patient centered and tailored to each individual. Dr. Alassas' clinical approach is based on collaborating with the patient and their treatment team to formulate a treatment plan that delivers the best potential outcome. This includes paying attention to details pertaining to both the patient and the disease process, applying best practice measures and excellent surgical skills, and utilizing innovative and cutting edge treatment methods. Clinical interests include surgical oncology, peritoneal surface malignancies, soft tissue tumors, retroperitoneal tumors, melanoma metastasectomy, clinical research, cancer prevention, and personalized cancer treatment. Dr. Alassas is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pseudomyxoma Peritonei, Pancreatectomy, and Hepato-Pancreato-Biliary Surgery.

Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Nasopharyngeal Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor.

Dr. Todd Barnett is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Barnett earned his medical degree from Northwestern University, Chicago, Ill. He completed his residency and fellowship at Stanford University, Calif. Dr. Barnett is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Pancreatic Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Follicular Thyroid Cancer.

Juan Mejia is a General Surgeon and a Transplant Surgeon in Moses Lake, Washington. Dr. Mejia is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection. Dr. Mejia is currently accepting new patients.

Wichit Srikureja is a Gastroenterologist in Spokane, Washington. Dr. Srikureja is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Bile Duct Stricture, Neuroma Biliary Tract, Cholestasis, Endoscopy, and Colonoscopy.

"Dr. Evan Ong most recently received the 2023 Cancer Surgery Top Doc designation and has received the Seattle Top Doc award for multiple consecutive years. Dr. Ong's clinical practice focuses on the treatment of all gastrointestinal cancers with particular interest in treatment options for pancreatico-biliary cancers as well as regional and metastatic disease. He offers state-of-the-art treatment including minimally invasive and robotic surgery for hepatic and pancreatic tumors, microwave and bipolar radiofrequency ablation, irreversible electroporation (Nano-knife) as well as Hyperthermic Intraperitoneal Chemoperfusion (HIPEC), a treatment option for cancers that have disseminated to the peritoneal cavity. Dr. Ong's philosophy of care is ""Qui Audet...Cura"" - ""Who Dares...Cures.""". Dr. Ong is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Colorectal Cancer, Pseudomyxoma Peritonei, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy.

Dr. Lechner is a graduate of the University of California at Los Angeles School of Medicine. He completed his oncology and hematology training at Oregon Health & Science University in Portland. Dr. Lechner is board certified in medical oncology and internal medicine. Dr. Lechner is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Waldenstrom Macroglobulinemia.

To treat each patient as an individual while realizing they are part of a family or the greater community. Dr. Mayeda is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Diabetic Nephropathy, Cholangiocarcinoma (Bile Duct Cancer), Type 2 Diabetes (T2D), and Intrauterine Growth Restriction.

More people survive cancer now than ever before. I see my role as being a strong advocate for my patients, fully informing them of their options and supporting them throughout their treatment programs. Dr. Fer is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

What I enjoy most about being a physician is getting to know my patients in the context of their lives. I value celebrating their new job, mourning a loss or meeting a dear family member. It is rewarding and interesting!. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Genital Warts, Keratosis Pilaris, and Orthostatic Hypotension.

Bruce Lin, MD, specializes in hematology and medical oncology, liver cancer, colorectal cancer and other gastrointestinal cancer, gastrointestinal oncology, colorectal care, liver, cancer, pancreatic cancer, bile duct cancer, and gastroesophageal cancer.Dr. Lin enjoys basketball, golf, fishing and photography. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Ampullary Cancer, Anal Cancer, and Lynch Syndrome.

Vincent Picozzi, Jr., MD, specializes in pancreatic cancer, gastrointestinal cancer (pancreaticobiliary), genitourinary cancer, hematologic oncology (lymphomas) and myelodysplasia. Dr. Picozzi is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Shayan Irani, MD, specializes in pancreaticobiliary diseases, gastrointestinal oncology, Barrett's Esophagus, gastrointestinal stenting, endoscopic mucosal resection, submucosal dissection, radio frequency ablation and other advanced therapeutic and emerging techniques.Dr. Irani enjoys spending time with his wife and daughter, the outdoors, traveling and Scuba diving. Dr. Irani is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholecystitis, Gastrointestinal Fistula, Hereditary Pancreatitis, Endoscopy, and Gastric Bypass.

"Scott Helton, MD, specializes in minimally invasive and open surgery of the liver, bile ducts, gallbladder, pancreas and spleen. He has a special interest in chronic pancreatitis, pancreatic cancer, liver cancer, bile duct tumors, repair of bile duct injuries, complex abdominal and inguinal hernias, and chronic groin pain after inguinal hernia repair.Dr. Helton is a Fellow of the American College of Surgeons.In his free time, Dr. Helton enjoys golfing, skiing and surfing.Curriculum VitaeAwards/AccoladesDirector, Liver, Pancreas and Biliary Surgical Center of Excellence, Virginia Mason, 2011-presentSenior Humanitarian Award; University of California, IrvineClosing Speaker, National Youth Leadership Foundation, ChicagoClinical Professor of Surgery, University of Washington, SeattlePast President, Seattle Surgical Society, 2020Past President, American Hepato-Pancreato-Biliary Association Foundation, 2012-2015Past President, American Hepato-Pancreato-Biliary Association, 2009-2010Past Treasurer, International Hepato-Pancreato-Biliary AssociationTeacher of the Year Award, Department of Surgery, Hospital of Saint Raphael, 2008Chairman, Department of Surgery, Hospital of St. Raphael's, CT, 2006-2011AOA Outstanding Clinical Director Teaching Award, UIC College of Medicine, 2005-2006Gastrointestinal Surgery Advisory Committee, American Board of Surgery, 2004-2009Olga Jonasson Award for Most Outstanding Teacher, Department of Surgery, University of Illinois, 2003Professor and Chair of Surgery, University of Illinois Chicago, 1998-2006Associate Professor of Surgery, University of Washington, 1996-1998Editorial Boards: HPB, Am J Surgery, World J Surgery, J of Pancreas, J Surgical Oncology, J Interventional Oncology, J Surgical Radiology, Gastrointestinal EndoscopySeattle Metropolitan Magazine, ""Seattle's Top Doctors"" 2011, 2012, 2013, 2015, 2016, 2019Castle Connolly Regional Top Doctor, 2019". Dr. Helton is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Gallbladder Removal.

Jeffrey Tokar is a Gastroenterologist in Tacoma, Washington. Dr. Tokar is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholestasis, Bile Duct Obstruction, Bile Duct Stricture, Endoscopy, and Colonoscopy. Dr. Tokar is currently accepting new patients.

Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.